Valuation: EMVision Medical Devices Ltd

Market Cap 164M 115M 100M 92.35M 84.89M 161M 11.02B 1.1B 433M 5.39B 430M 421M 18.56B P/E 2026 *
-18x
P/E 2027 * -15.6x
Enterprise Value 164M 115M 100M 92.35M 84.89M 161M 11.02B 1.1B 433M 5.39B 430M 421M 18.56B EV / Sales 2026 *
29.7x
EV / Sales 2027 * 32.7x
Free-Float
66.78%
Yield 2026 *
-
Yield 2027 * -
1 day-4.55%
1 week+11.26%
Current month+10.89%
1 month+9.09%
3 months+7.01%
6 months-6.67%
Current year-5.62%
1 week 1.47
Extreme 1.47
1.76
1 month 1.47
Extreme 1.47
1.76
Current year 1.47
Extreme 1.47
1.96
1 year 1.47
Extreme 1.47
2.43
3 years 1.16
Extreme 1.16
2.72
5 years 1.13
Extreme 1.13
3.35
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 01/07/2023
Director of Finance/CFO - 01/02/2026
Chief Tech/Sci/R&D Officer - 01/07/2023
Director TitleAgeSince
Director/Board Member 80 29/09/2020
Director/Board Member - 05/06/2025
Director/Board Member - 01/07/2018
Date Insider Type Main position Quantity % Market Cap.
04-23Buy

Director

10,000 0.0108%
01-02Expiration

Chairman

300,000 0.3228%
11-18Free

Director

200,000 0.2176%
Change 5-day change 1-year change 3-year change Capi.($)
-4.55%+11.26%-3.45%+41.77% 99.06M
+0.23%+4.93%+28.06%+1.12% 198B
+0.87%+5.25%+4.11%-16.52% 141B
+2.50%-6.29%-24.06%+9.88% 134B
+0.96%-3.95%-58.41%-18.84% 63.36B
-3.13%-6.80%+13.62%-6.54% 51.87B
+1.34%+1.46%-24.75%-32.76% 43.77B
-0.36%+4.37%+19.28%+12.49% 38.18B
-0.39%+1.84%+29.48%+38.46% 36.96B
-2.12%-0.35%+92.64%0.00% 28.93B
Average -0.90%-0.41%+7.65%+2.91% 73.69B
Weighted average by Cap. -0.20%+0.27%+4.54%-2.50%

Financials

2026 *2027 *
Net sales 5.5M 3.85M 3.37M 3.1M 2.85M 5.41M 370M 37.06M 14.54M 181M 14.46M 14.14M 624M 5M 3.5M 3.06M 2.82M 2.59M 4.92M 337M 33.69M 13.22M 165M 13.14M 12.85M 567M
Net income -9.1M -6.37M -5.57M -5.14M -4.72M -8.95M -613M -61.32M -24.06M -300M -23.92M -23.39M -1.03B -12M -8.4M -7.34M -6.77M -6.23M -11.8M -808M -80.87M -31.73M -395M -31.54M -30.85M -1.36B
Net Debt - -
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
16/07/26 A$1.680 -4.55% 30,973
15/07/26 A$1.760 +15.41% 34,279
14/07/26 A$1.525 +1.33% 75,809
13/07/26 A$1.505 +0.33% 32,218
10/07/26 A$1.500 -0.66% 31,574
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.760AUD
Average target price
3.150AUD
Spread / Average Target
+78.98%

Annual profits - Rate of surprise